Article info

Download PDFPDF

Evaluation of the safety of live attenuated influenza vaccine (LAIV) in children and adolescents with asthma and high-risk conditions: a population-based prospective cohort study conducted in England with the Clinical Practice Research Datalink

Authors

  1. Correspondence to Dr Herve Caspard; caspardh{at}medimmune.com
View Full Text

Citation

Caspard H, Steffey A, Mallory RM, et al
Evaluation of the safety of live attenuated influenza vaccine (LAIV) in children and adolescents with asthma and high-risk conditions: a population-based prospective cohort study conducted in England with the Clinical Practice Research Datalink

Publication history

  • Received March 21, 2018
  • Revised October 29, 2018
  • Accepted November 13, 2018
  • First published December 9, 2018.
Online issue publication 
December 09, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.